Sphere Medical Holding (LSE:SPHR) Capex-to-Revenue : 40.67 (As of Dec. 2016)

View and export this data going back to 2011. Start your Free Trial

What is Sphere Medical Holding Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Sphere Medical Holding's Capital Expenditure for the six months ended in Dec. 2016 was £-0.98 Mil. Its Revenue for the six months ended in Dec. 2016 was £0.02 Mil.

Hence, Sphere Medical Holding's Capex-to-Revenue for the six months ended in Dec. 2016 was 40.67.

Sphere Medical Holding Capex-to-Revenue Historical Data

The historical data trend for Sphere Medical Holding's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sphere Medical Holding Capex-to-Revenue Chart

Sphere Medical Holding Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Capex-to-Revenue

Get a 7-Day Free Trial

6.02

3.08

2.71

66.20

75.73

Sphere Medical Holding Semi-Annual Data
	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16
Capex-to-Revenue	Get a 7-Day Free Trial						4.83	6.40	185.80	216.00	40.67

Competitive Comparison of Sphere Medical Holding's Capex-to-Revenue

For the Medical Devices subindustry, Sphere Medical Holding's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sphere Medical Holding's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sphere Medical Holding's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sphere Medical Holding's Capex-to-Revenue falls into.

Sphere Medical Holding Capex-to-Revenue Calculation

Sphere Medical Holding's Capex-to-Revenue for the fiscal year that ended in Dec. 2016 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-2.272)	/	0.03
	=	75.73

Sphere Medical Holding's Capex-to-Revenue for the quarter that ended in Dec. 2016 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-0.976)	/	0.024
	=	40.67

Sphere Medical Holding (LSE:SPHR) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

Sphere Medical Holding Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sphere Medical Holding's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sphere Medical Holding (LSE:SPHR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sphere Medical Holding PLC (LSE:SPHR) » Definitions » Capex-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Harston Mill, Harston, Cambridge, GBR, CB22 7GG

Website

http://www.spheremedical.com

Sphere Medical Holding Ltd is a UK-based company which is engaged in research and development, manufacturing and sale of medical monitoring and diagnostic equipment within the medical device area. It focuses on developing the Proxima platform for measuring blood gases, electrolytes and metabolites. Proxima is an in-line patient dedicated arterial blood analyser which supports frequent measurements at critical times. It markets its product (Proxima) to critical care market which includes ICU (Intensive Care Unit) and OR (Operating Room). The company's products are used in medical applications, enabling faster clinical decision-making and improved patient outcomes. It operates is business in single reporting segment of Medical devices. Most of the company's revenue comes from Europe.